Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-17

FDA Approved: ZILEUTON — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings, Inc.'s original ANDA for zileuton, enabling a generic zileuton product for the treatment of asthma. This marks the first ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zileuton (zileuton)

Snippet

ORIG AP for ZILEUTON (ZILEUTON)